Atlantis Formulations Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Vogtis GM 2mg/500mg/0.3mg Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Vogtis GM 2mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Vogtis GM 2mg/500mg/0.3mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Vogtis GM 2mg/500mg/0.3mg Tablet.
Vogtis GM 2mg/500mg/0.3mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Vogtis GM 2mg/500mg/0.3mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Vogtis GM 2mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Vogtis GM 2mg/500mg/0.3mg Tablet is a combination of Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin works by lowering glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels in the body.
Side effects associated with Vogtis GM 2mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Avoid using Vogtis GM 2mg/500mg/0.3mg Tablet if you have allergies to any of its components or excipients, are experiencing moderate to severe kidney disease, have inflammatory bowel disease, colonic ulcerations or underlying metabolic acidosis including diabetic ketoacidosis.
No, combining Vogtis GM 2mg/500mg/0.3mg Tablet with alcohol is not advisable as this could lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, using Vogtis GM 2mg/500mg/0.3mg Tablet can lead to hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It is more likely to occur when missing meals, drinking alcohol, exercising excessively, or taking other antidiabetic medication alongside it. Regular blood sugar monitoring is essential.
Store this medicine in its original packaging, tightly closed. Follow the storage recommendations provided on the packaging or label. Dispose of unused medication according to local guidelines. Never share this medicine with others, and keep it out of reach of pets, children, and other unauthorized individuals.